We are live on ! Find out more
Walleye Capital

Walleye Capital Portfolio holdings

AUM $24B
1-Year Est. Return 37.67%
This Fund
S&P 500
This Quarter Est. Return
+18.63%
1 Year Est. Return
+37.67%
3 Year Est. Return
+98.01%
5 Year Est. Return
+160%
10 Year Est. Return
–
AUM
$607M
AUM Growth
–
Cap. Flow
+$583M
Cap. Flow %
96.07%
Top 10 Hldgs %
4.88%
Holding
1,467
New
1,467
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
SHLL.U
Tortoise Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-half
SHLL.U
+$3M
2
JFKKU
8i Enterprises Acquisition Corp Unit
JFKKU
+$2.51M
3
TRNE.U
Trine Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-half of
TRNE.U
+$2.25M
4
AMCIU
AMCI Acquisition Corp Unit
AMCIU
+$2M
5
LVOXU
LiveVox Holding, Inc. Unit
LVOXU
+$2M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 1.29%
2 Consumer Discretionary 1.08%
3 Technology 1.07%
4 Industrials 0.79%
5 Financials 0.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TNDM icon
1451
Tandem Diabetes Care
TNDM
$1.17B
$4K ﹤0.01%
+60
New +$3.15K
SMAR
1452
PUT
DELISTED
Smartsheet Inc.
SMAR
$4K ﹤0.01%
+100
New +$3.46K
BIG
1453
PUT
DELISTED
Big Lots, Inc.
BIG
$4K ﹤0.01%
+100
New +$3.26K
B
1454
CALL
Barrick Mining
B
$62.2B
$3K ﹤0.01%
+200
New +$2.58K
NI icon
1455
PUT
NiSource
NI
$22.4B
$3K ﹤0.01%
+100
New +$2.7K
NTGR icon
1456
NETGEAR
NTGR
$669M
$3K ﹤0.01%
+100
New +$3.63K
SCS
1457
PUT
DELISTED
Steelcase
SCS
$3K ﹤0.01%
+200
New +$3.32K
PTLA
1458
CALL
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$3K ﹤0.01%
+100
New +$2.88K
AKBA icon
1459
PUT
Akebia Therapeutics
AKBA
$327M
$2K ﹤0.01%
+300
New +$2.06K
HSIC icon
1460
Henry Schein
HSIC
$9.74B
$2K ﹤0.01%
+30
New +$1.81K
PDD icon
1461
PUT
Pinduoduo
PDD
$118B
$2K ﹤0.01%
+100
New +$2.68K
WDFC icon
1462
WD-40
WDFC
$3.1B
$2K ﹤0.01%
+10
New +$1.76K
AYX
1463
DELISTED
Alteryx Inc
AYX
$2K ﹤0.01%
+20
New +$1.44K
CARB
1464
CALL
DELISTED
Carbonite Inc
CARB
$2K ﹤0.01%
+100
New +$2.57K
AMRX icon
1465
Amneal Pharmaceuticals
AMRX
$5.72B
$1K ﹤0.01%
+100
New +$1.32K
CROX icon
1466
Crocs
CROX
$6.69B
$1K ﹤0.01%
+34
New +$931
QDEL icon
1467
QuidelOrtho
QDEL
$1.09B
$1K ﹤0.01%
+22
New +$1.33K
55 56 57 58
59

Similar funds

Teacher Retirement System of Texas
Teacher Retirement System of Texas Austin, Texas $24B AUM 29.51% 1-Year Est. Return
JG
Jain Global New York $24.2B AUM 34.82% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
SC
Scotia Capital Toronto, Ontario, Canada $24.3B AUM 29.21% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Walleye Capital's Q1 2019 Portfolio in Review

Q1 2019 is the first quarter with a 13F filing on record for Walleye Capital, which disclosed 1,467 positions worth $607M. Its ten largest holdings account for 4.9% of the portfolio.

Its largest position is Tortoise Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-half: 300,000 shares worth $3M.

By sector, the portfolio is most concentrated in Healthcare at 1.3% of assets, followed by Consumer Discretionary and Technology.

  • Walleye Capital's largest Q1 2019 buy was Tortoise Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-half: 300,000 shares worth $3M.
  • Walleye Capital's ten largest holdings make up 4.9% of its $607M portfolio in Q1 2019.
  • Walleye Capital disclosed 1,467 positions in Q1 2019, its first 13F filing on record.

Based on Walleye Capital's 13F filing for Q1 2019, filed 15 May 2019.